LSM1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.751800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.924600E-01
Normal-vs-Stage2
8.739600E-01
Normal-vs-Stage3
7.118200E-01
Normal-vs-Stage4
6.024400E-01
Stage1-vs-Stage2
8.363200E-01
Stage1-vs-Stage3
7.095000E-01
Stage1-vs-Stage4
5.503400E-01
Stage2-vs-Stage3
7.804000E-01
Stage2-vs-Stage4
1.472190E-01
Stage3-vs-Stage4
9.471600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.721400E-01
Normal-vs-AfricanAmerican
8.297000E-01
Normal-vs-Asian
8.215400E-01
Caucasian-vs-AfricanAmerican
6.362400E-01
Caucasian-vs-Asian
9.945200E-01
AfricanAmerican-vs-Asian
5.288200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.901000E-01
Normal-vs-Female
8.550800E-01
Male-vs-Female
9.639200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.924590E-01
Normal-vs-Age(41-60Yrs)
8.140200E-01
Normal-vs-Age(61-80Yrs)
9.151800E-01
Normal-vs-Age(81-100Yrs)
5.953200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.300100E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.789600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.001200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.671400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.685000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.479400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.914000E-01
Normal-vs-Daily Drinker
9.699000E-01
Normal-vs-Weekly Drinker
6.531000E-01
Normal-vs-Occasional Drinker
7.420000E-01
Normal-vs-Social Drinker
9.188400E-01
Non Drinker-vs-Daily Drinker
8.895400E-01
Non Drinker-vs-Weekly Drinker
2.033400E-01
Non Drinker-vs-Occasional Drinker
4.016000E-01
Non Drinker-vs-Social Drinker
8.513600E-01
Daily Drinker-vs-Weekly Drinker
3.860200E-01
Daily Drinker-vs-Occasional Drinker
6.194200E-01
Daily Drinker-vs-Social Drinker
9.897000E-01
Weekly Drinker-vs-Occasional Drinker
5.404600E-01
Weekly Drinker-vs-Social Drinker
3.015600E-01
Occasional Drinker-vs-Social Drinker
4.104400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.893800E-01
Normal-vs-Grade 2
3.842000E-01
Normal-vs-Grade 3
3.769600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.908200E-02
Grade 1-vs-Grade 3
7.464200E-02
Grade 1-vs-Grade 4
6.893800E-01
Grade 2-vs-Grade 3
6.461800E-01
Grade 2-vs-Grade 4
3.842000E-01
Grade 3-vs-Grade 4
3.769600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.646400E-01
Normal-vs-NonDiabetic
7.817600E-01
Diabetic-vs-NonDiabetic
9.115800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.888000E-01
Normal-vs-NoPancreatitis
8.619400E-01
Pancreatitis-vs-NoPancreatitis
4.726000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.963600E-01
Normal-vs-N1
8.476400E-01
N0-vs-N1
8.583000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.087000E-01
Normal-vs-TP53-NonMutant
7.527400E-01
TP53-Mutant-vs-TP53-NonMutant
5.519100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
